ResearcherInsermNo recent work listed
Antoine Drouillard
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-22-946↗
- [Epidemiology of pancreatic cancer]. Co-author DOI 10.1016/j.bulcan.2017.11.004↗
- Focus on an unusual rise in pancreatic cancer incidence in France. Last author DOI 10.1093/ije/dyx088↗
- DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. Co-author DOI 10.1038/bjc.2016.319↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sylvain Manfrédi · 2 shared papers, 2018–2023 · strength 0.24
- Côme Lepage · 2 shared papers, 2018–2023 · strength 0.24
- Anne‐Marie Bouvier · 2 shared papers, 2017–2018 · strength 0.19
- Jean‐Baptiste Bachet · 2 shared papers, 2016–2023 · strength 0.18
- Noelle K. LoConte · 1 shared paper, 2023 · strength 0.12
- Jerome F. Cros · 1 shared paper, 2023 · strength 0.12
- David Piquemal · 1 shared paper, 2023 · strength 0.12
- Christophe Tournigand · 1 shared paper, 2023 · strength 0.12
- Emmanuelle Kempf · 1 shared paper, 2023 · strength 0.12
- Émilie Soularue · 1 shared paper, 2023 · strength 0.12
- Cindy Canivet · 1 shared paper, 2023 · strength 0.12
- Isabelle Trouilloud · 1 shared paper, 2023 · strength 0.12
- François Ghiringhelli · 1 shared paper, 2023 · strength 0.12
- Barbara Bournet · 1 shared paper, 2023 · strength 0.12
- Valérie Jooste · 1 shared paper, 2017 · strength 0.08
- Raphaël Maréchal · 1 shared paper, 2016 · strength 0.06
- Pieter Demetter · 1 shared paper, 2016 · strength 0.06
- Jean‐Luc Van Laethem · 1 shared paper, 2016 · strength 0.06
- Francesco Puleo · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.